BRIEF-Celgene gets positive CHMP opinion for abraxane

Fri Nov 22, 2013 7:36am EST

Nov 22 (Reuters) - Celgene Corp : * Receives positive CHMP opinion for abraxane in combination with gemcitabine as treatment for patients with metastatic pancreatic cancer * Says European Commission, which generally follows recommendation of the chmp, is expected to make final decision within two to three months * Source text for Eikon * Further company coverage